TransMedics Group, Inc. (TMDX) Operating income 2018–2025
TransMedics Group, Inc. (TMDX) annual operating income history from SEC filings — each fiscal year as reported.
$108.6MFY2025 · since FY2018: -$20.2M → $108.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $108.6M | +189.6% |
| FY2024 | $37.5M | +230.5% |
| FY2023 | -$28.7M | +8.6% |
| FY2022 | -$31.4M | +20.3% |
| FY2021 | -$39.4M | -49.4% |
| FY2020 | -$26.4M | +10.9% |
| FY2019 | -$29.6M | -46.3% |
| FY2018 | -$20.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TMDX financial trends
TMDX RevenueTMDX Net incomeTMDX Net marginTMDX Gross profitTMDX Gross marginTMDX Operating marginTMDX Operating cash flowTMDX Free cash flowTMDX Capital expendituresTMDX Return on equityTMDX Stock buybacksTMDX Dividends paidTMDX Total assetsTMDX Total liabilitiesTMDX Shareholders’ equityTMDX overview →